With these effects and its high average THC level, Blue Heron is said to be perfect for treating conditions such as chronic stress, migraines or headaches, chronic fatigue, nausea or appetite loss, and depression.
Blue Heron *GAS* (AAAAA)
$70-$220 | 31% THC
INDICA-DOMINANT HYBRID (60% INDICA | 40% SATIVA)
cerebral, euphoria, giggly, relaxing, uplifting
depression, fatigue, migraines, nausea, stress
berry, citrus, lemon, sour, sweet
berry, citrus, earthy, lemon, sour
Blue Heron is a slightly indica-dominant hybrid strain (60% indica/40% sativa) created through crossing the classic Blue Magoo X Huckleberry strains. When it comes to insanely gorgeous appearances, Blue Heron has it all.
This bud has fluffy heart-shaped olive green nugs with rich vibrant blue undertones, golden amber hairs, and a coating of golden crystal trichomes that look almost blue in the right light. As you break apart each sticky little nugget, fresh aromas of sweet berries and sour citrus are released, with a light earthy effect, too. The flavour is of sweet citrus and berries with a touch of sour herbs upon exhale.
The Blue Heron high is just as amazing as the flavour, with full-bodied effects that will leave you lifted for hours on end. You’ll feel a cerebral rush at the onset of the high that smashes its way into your brain, replacing any negative or racing thoughts with pure unfocused bliss. As your mind soars, you’ll feel a case of the giggles settle in, leaving you laughing at anything and everything around you for hours and hours on end. This heady state is accompanied by a lightly relaxing body high that keeps you anchored to the world below as your mind soars.
Want to mix and match this strain? Click here.
For more information about this strain, click here.
To check out our current promotions, click here.
SALE! REG. $80
$40-$60 | 21% THC
SALE! reg. $150
26% THC SATIVA-DOMINANT HYBRID
$55-$150 | 28% THC
$50-$125 | 24% THC
$60-$99 | 22% THC
$60-$180 | 28% THC
20% THC INDICA-DOMINANT HYBRID
SALE! Reg. $150
$50-125 | 26% THC
There are no reviews yet.